Atorvastatin doesn’t just lower bad cholesterol — it also lowers overall cholesterol and a key protein linked to heart disease, and higher doses make these effects stronger.

57

Pro

0

Against

Evidence from Studies

Supporting (1)

57

Community contributions welcome

57

Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor.

Randomized Controlled Trial

Human

1995 May

This study gave different doses of atorvastatin to people with high cholesterol and found that higher doses lowered not just LDL ('bad') cholesterol, but also total cholesterol and apo B — two other important fat markers — proving the drug works on multiple types of fats in the blood.

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Source Study

Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor.

Score: 57

DOI: 10.1161/01.ATV.15.5.678

Similar Assertions

This new statin, atorvastatin, lowers bad cholesterol more than older statins have been shown to in past studies.

57

0

86%

Taking atorvastatin every day for 6 weeks can lower 'bad' cholesterol by up to 60% in people with high cholesterol, and the higher the dose, the more it drops.

57

0

81%

In this short study, atorvastatin didn’t cause serious side effects in people with high cholesterol, making it safe enough to consider for treatment.

57

0

81%

The same cholesterol drug also made fewer bad cholesterol particles (LDL) in pigs by slowing down how much was made, not by clearing them faster.

11

0

78%

The cholesterol-lowering drug atorvastatin doesn’t get into the fatty plaques in arteries — so it must be working by lowering cholesterol in the blood, not by directly touching the immune cells inside the plaque.

0

61

78%